• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    IFF and Kemira Form Joint Venture To Produce Sustainable Biobased Materials at Scale

    3/27/25 2:00:00 AM ET
    $IFF
    Major Chemicals
    Industrials
    Get the next $IFF alert in real time by email

    Joint venture Alpha Bio will use IFF's proprietary Designed Enzymatic Biomaterials™ technology to provide high-performance, sustainable alternatives to fossil-based ingredients

    IFF (NYSE:IFF) and Kemira announced the formation of Alpha Bio, a joint venture aimed at commercial-scale production of renewable biobased materials. With an investment of approximately €130 million, the Alpha Bio facility will start production in late 2027, converting up to 44,000 MT of plant sugars to bioproducts, including high-performance biopolymers for use in various applications, such as home and personal care and industrial solutions. Alpha Bio's production will use IFF's Designed Enzymatic Biomaterial™ (DEB) platform technology, integrated at the IFF biorefinery in Kotka, Finland.

    "Our partnership with Kemira has reached a significant milestone, enabling us to scale the production of groundbreaking biobased materials to meet the large and growing demand for high-performing and sustainable alternatives to fossil-derived polymers," said Erik Fyrwald, IFF CEO. "IFF's DEB technology not only guarantees superior purity and consistency compared to traditional biopolymers but also enhances performance across various applications. This innovative approach allows us to combine biodegradability and material sustainability while maintaining cost efficiency and the high performance our customers expect."

    IFF's DEB platform leverages biotechnology by using plant-based sugars and enzymes under mild process conditions to create biobased materials, which can be tailored for specific product applications. This allows manufacturers to replace traditional fossil-based synthetic polymers with more sustainable alternatives. This highly efficient enzymatic polymerization process converts plant sugars to biopolymers, offering superior purity and consistency compared to conventional synthetic polymers. These tailored biopolymers enhance product performance across diverse applications.

    "Since 2020, we've been collaborating with IFF using the DEB platform technology, which has allowed us to bring sustainable innovation to our key markets," said Antti Salminen, CEO, Kemira Oyj. "The new joint venture will build on this initial success, enabling us to scale up production and provide new performance-competitive alternatives to fossil-based products in key markets, including paper and board packaging, paper coatings, and water treatment, while continuing to develop opportunities across other growth markets."

    Operating as an independent entity in Kotka, Finland, the joint venture will manufacture a specific line of products enabled by DEB technology for exclusive use by IFF and Kemira. The creation of Alpha Bio is expected to generate approximately 30 direct new jobs in the Kotka area with additional job creation during the project's construction phase.

    Visit www.iff.com for more information.

    Cautionary Statement under the Private Securities Litigation Reform Act of 1995

    This press release contains "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as ""plan", "expect," "anticipate," "intend," "believe," "seek," "see," "will," "would," "target," similar expressions, and variations or negatives of these words. Forward-looking statements by their nature address matters that are, to different degrees, uncertain, such as statements about the timing or nature of the proposed expansion. The forward-looking statements included in this release are made only as of the date hereof, and we undertake no obligation to update the forward-looking statement to reflect subsequent events or circumstances.

    Welcome to IFF

    At IFF (NYSE:IFF), we make joy through science, creativity, and heart. As the global leader in flavors, fragrances, food ingredients, health and biosciences, we deliver groundbreaking, sustainable innovations that elevate everyday products—advancing wellness, delighting the senses and enhancing the human experience. Learn more at iff.com, LinkedIn, Instagram and Facebook.

    Welcome to Kemira

    Kemira is a global leader in sustainable chemical solutions for water-intensive industries. We deliver tailored products and services to improve the product quality, processes, and resource efficiency of our diverse range of customers. Our focus is on water treatment, as well as on fiber and renewable solutions – enabling sustainability transformation for our customers. In 2024, Kemira reported annual revenue of EUR 2.9 billion with a global team of some 4,700 colleagues. Kemira is listed on the Nasdaq, Helsinki. More information: www.kemira.com

    ©2025 International Flavors & Fragrances Inc. (IFF). IFF, the IFF Logo, and all trademarks and service marks denoted with ™, ℠ or ® are owned by IFF or affiliates of IFF unless otherwise noted. All Rights Reserved.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250326146003/en/

    Media Relations:

    Paulina Heinkel

    332.877.5339

    [email protected]

    Investor Relations:

    Michael Bender

    212.708.7263

    [email protected]

    Get the next $IFF alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $IFF

    DatePrice TargetRatingAnalyst
    2/13/2026$97.00Perform → Outperform
    Oppenheimer
    9/8/2025Underperform → Peer Perform
    Wolfe Research
    8/7/2025Outperform → Perform
    Oppenheimer
    6/4/2025$105.00Buy
    Tigress Financial
    5/8/2025$84.00Equal Weight → Overweight
    Barclays
    2/20/2025$77.00Buy → Sell
    CFRA
    1/7/2025Hold → Buy
    Argus
    11/12/2024$111.00 → $110.00Equal-Weight → Overweight
    Morgan Stanley
    More analyst ratings

    $IFF
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    IFF Launches PureStrong™, a Probiotic Made Specifically for Dogs

    IFF (NYSE:IFF)—a global leader in flavors, fragrances, food ingredients and health & biosciences—is introducing PureStrong™, a new probiotic developed exclusively for canine digestive health. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260401736960/en/IFF introduces PureStrong™, a probiotic made specifically for dogs. Today, many people consider their pet dogs part of the family. This shift is fueling rapid growth in the $3.2 billion U.S. pet supplement market. With nearly half of U.S. pet owners having purchased or considering probiotics for their dogs, PureStrong™ sets a new standard: pet‑first science built specifically fo

    4/2/26 8:15:00 AM ET
    $IFF
    Major Chemicals
    Industrials

    IFF Secures First Heart Health Claim for Soy Protein in Australia and New Zealand

    Regulatory milestone opens heart health growth opportunities for food and beverage manufacturers IFF (NYSE:IFF), a global leader in flavors, fragrances, food ingredients and health & biosciences announced today that a new heart health claim for isolated soy protein has been accepted by the Food Standards Australia New Zealand (FSANZ). The approval enables food and beverage manufacturers in Australia and New Zealand to link soy protein consumption with healthy blood cholesterol levels. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330523416/en/First heart health claim approved for soy protein in Australia and New Zealand. "

    3/31/26 10:00:00 AM ET
    $IFF
    Major Chemicals
    Industrials

    IFF Expands Latin American Footprint With New Enzyme Hub, Brazil Application Lab

    IFF (NYSE:IFF) — a global leader in flavors, fragrances, food ingredients and health & biosciences — is enhancing regional production and innovation capabilities to better support the continued growth of its Health & Biosciences (H&B) business in Latin America, one of the fastest-growing markets for the company. The effort includes the transformation of the Arroyito site in Argentina into IFF's first full fermentation‑based enzyme production hub in the region and the opening of a household care application laboratory at IFF's Innovation Center in Brazil. Together, these enhancements expand IFF's regional footprint and are expected to improve speed, reliability and locally relevant solutions

    3/10/26 4:30:00 PM ET
    $IFF
    Major Chemicals
    Industrials

    $IFF
    SEC Filings

    View All

    SEC Form DEF 14A filed by International Flavors & Fragrances Inc.

    DEF 14A - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Filer)

    3/18/26 8:00:42 AM ET
    $IFF
    Major Chemicals
    Industrials

    SEC Form DEFA14A filed by International Flavors & Fragrances Inc.

    DEFA14A - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Filer)

    3/18/26 8:01:20 AM ET
    $IFF
    Major Chemicals
    Industrials

    SEC Form 10-K filed by International Flavors & Fragrances Inc.

    10-K - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Filer)

    2/27/26 5:16:10 PM ET
    $IFF
    Major Chemicals
    Industrials

    $IFF
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Fyrwald J Erik

    4 - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Issuer)

    4/3/26 4:14:20 PM ET
    $IFF
    Major Chemicals
    Industrials

    SEC Form 4 filed by Finzel Ralf

    4 - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Issuer)

    4/3/26 4:14:18 PM ET
    $IFF
    Major Chemicals
    Industrials

    SEC Form 4 filed by Birenkrant Marc

    4 - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Issuer)

    4/3/26 4:13:16 PM ET
    $IFF
    Major Chemicals
    Industrials

    $IFF
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Intl Flavors upgraded by Oppenheimer with a new price target

    Oppenheimer upgraded Intl Flavors from Perform to Outperform and set a new price target of $97.00

    2/13/26 7:54:07 AM ET
    $IFF
    Major Chemicals
    Industrials

    Intl Flavors upgraded by Wolfe Research

    Wolfe Research upgraded Intl Flavors from Underperform to Peer Perform

    9/8/25 8:37:37 AM ET
    $IFF
    Major Chemicals
    Industrials

    Intl Flavors downgraded by Oppenheimer

    Oppenheimer downgraded Intl Flavors from Outperform to Perform

    8/7/25 7:47:58 AM ET
    $IFF
    Major Chemicals
    Industrials

    $IFF
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Fribourg Paul J bought $10,971,329 worth of shares (156,459 units at $70.12) and sold $14,481 worth of shares (222 units at $65.23), increasing direct ownership by 92% to 29,650 units (SEC Form 4)

    4 - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Issuer)

    3/16/26 4:33:49 PM ET
    $IFF
    Major Chemicals
    Industrials

    Chief Executive Officer Fyrwald J Erik bought $995,204 worth of shares (14,260 units at $69.79), increasing direct ownership by 18% to 91,630 units (SEC Form 4)

    4 - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Issuer)

    3/16/26 4:33:47 PM ET
    $IFF
    Major Chemicals
    Industrials

    EVP, General Counsel Landsman Stephen N bought $196,788 worth of shares (3,100 units at $63.48), increasing direct ownership by 26% to 15,100 units (SEC Form 4)

    4 - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Issuer)

    12/12/25 4:18:29 PM ET
    $IFF
    Major Chemicals
    Industrials

    $IFF
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by International Flavors & Fragrances Inc. (Amendment)

    SC 13G/A - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Subject)

    3/8/24 4:44:49 PM ET
    $IFF
    Major Chemicals
    Industrials

    SEC Form SC 13G/A filed by International Flavors & Fragrances Inc. (Amendment)

    SC 13G/A - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Subject)

    2/13/24 5:07:58 PM ET
    $IFF
    Major Chemicals
    Industrials

    SEC Form SC 13G filed by International Flavors & Fragrances Inc.

    SC 13G - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Subject)

    2/13/24 2:02:27 PM ET
    $IFF
    Major Chemicals
    Industrials

    $IFF
    Financials

    Live finance-specific insights

    View All

    IFF Declares Dividend for First Quarter 2026

    IFF (NYSE:IFF) announced that its Board of Directors has declared a regular quarterly cash dividend of $0.40 per share of its common stock, payable on April 10, 2026 to shareholders of record as of March 20, 2026. Welcome to IFF At IFF (NYSE:IFF), we make joy through science, creativity and heart. As the global leader in flavors, fragrances, food ingredients, health and biosciences, we deliver groundbreaking, sustainable innovations that elevate everyday products—advancing wellness, delighting the senses and enhancing the human experience. Learn more at iff.com, LinkedIn, Instagram and Facebook. © 2026 by International Flavors & Fragrances Inc. IFF is a Registered Trademark. All Rights

    3/4/26 4:15:00 PM ET
    $IFF
    Major Chemicals
    Industrials

    IFF Reports Fourth Quarter and Full Year 2025 Results

    Delivered solid top and bottom-line performance & advanced strategic priorities in 2025 Launched sale process for the Food Ingredients segment Continuing to drive financial performance in 2026 International Flavors & Fragrances Inc. (NYSE:IFF) reported financial results for the fourth quarter and full year ended December 31, 2025. Full year 2025 Consolidated Summary: Reported   Adjusted (GAAP) (Non-GAAP)1 Sales   Loss Before Taxes   EPS   Operating EBITDA   Operating EBITDA Margin   EPS ex Amortization $10.9 B   $(412) M   $(1.46)   $2.1 B

    2/11/26 4:15:00 PM ET
    $IFF
    Major Chemicals
    Industrials

    IFF to Release Fourth Quarter & Full Year 2025 Results on Feb. 11, 2026; IFF to Present at 2026 CAGNY Conference on Feb. 19, 2026

    IFF (NYSE:IFF) today announced that it will release its fourth quarter and full year 2025 earnings results following the market close on Wednesday, Feb. 11, 2026. The management team will host a live webcast on Thursday, Feb. 12, 2026, at 9:00 a.m. ET to discuss results and outlook with the investor community. IFF also announced today that the Company's management will speak at the Consumer Analyst Group of New York (CAGNY) conference on Thursday, Feb. 19, 2026 at 1:00 PM ET. Investors may access the live webcast and accompanying slide presentation on the Company's website at ir.iff.com. For those unable to listen to the live webcast, a recorded version will be made available for replay

    1/21/26 4:15:00 PM ET
    $IFF
    Major Chemicals
    Industrials

    $IFF
    Leadership Updates

    Live Leadership Updates

    View All

    Mativ Announces Appointment of Seasoned Executive to Its Board of Directors

    Deborah Borg Brings 25+ Years of Corporate Leadership to Global Manufacturing Leader Mativ Holdings, Inc. (NYSE:MATV) announced today the appointment of Deborah Borg to its Board of Directors, effective immediately. In her role on the Mativ Board of Directors, Borg will serve on the Company's Compensation Committee and Nominating & Governance Committee. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251124104625/en/Deborah Borg, Mativ Board of Directors Borg is currently the Executive Vice President, Chief People & Culture Officer at International Flavors & Fragrances Inc. (NYSE:IFF), a global leader in food, beverage, health, b

    11/24/25 4:05:00 PM ET
    $IFF
    $MATV
    $SWM
    Major Chemicals
    Industrials
    Paper
    Basic Materials

    IFF Announces Appointment of Brett Icahn and Richard Mulligan to Board of Directors

    IFF (NYSE:IFF)—a global leader in flavors, fragrances, food ingredients, health and biosciences—today announced the appointment of Brett Icahn and Richard Mulligan, Ph.D., to its board of directors, effective Oct. 20. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251022380951/en/Brett Icahn (Photo: IFF) These appointments follow the company's previously disclosed cooperation agreement with Icahn Capital LP and its affiliates. Icahn serves as the Icahn designee to the IFF board, replacing Vincent Intrieri, and Mulligan joined as the mutually agreed independent director, replacing Margarita Paláu-Hernández. Intrieri and Paláu-Her

    10/22/25 4:15:00 PM ET
    $IFF
    Major Chemicals
    Industrials

    /C O R R E C T I O N -- National Association of Corporate Directors/

    In the news release, Global Leaders Jesús Mantas and Wes Bricker Join NACD Board of Directors, issued 10-Oct-2025 by National Association of Corporate Directors over PR Newswire, we are advised by the company that the third paragraph, the end of the last line, should read "IBM Business Transformation Services" instead of "IBM Consulting Business Transformation Services" as originally issued inadvertently. The complete, corrected release follows: Global Leaders Jesús Mantas and Wes Bricker Join NACD Board of Directors Seasoned executives bring deep expertise in innovation, governance, and business to strengthen NACD's leadership board excellence WASHINGTON, Oct. 10, 2025 /PRNewswire/ -- Th

    10/10/25 10:00:00 AM ET
    $BIIB
    $IFF
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Major Chemicals
    Industrials